|
|
Effect of family pharmacist responsibility system on compliance and prognosis of patients with atrial fibrillation taking Warfarin |
DING Xiaoli1 WANG Song1 ZHOU Chunqiao1 WANG Hu1 LIU Hailin1 ZHANG Xuelin1 LIU Huanyun2 |
1.Department of Pharmacy, the First People’s Hospital of Chongqing Liang Jiang New Area, Chongqing 401120, China;
2.Department of Cardiology, the First People’s Hospital of Chongqing Liang Jiang New Area, Chongqing 401120, China |
|
|
Abstract Objective To study the effect of family pharmacist responsibility system on compliance and prognosis of patients with atrial fibrillation (AF) taking Warfarin. Methods A total of 120 patients with AF admitted to the First People’s Hospital of Chongqing Liang Jiang New Area from June 2017 to June 2019 as the research objects, they were divided into the control group (56 cases) and the observation group (64 cases) according to a random number table method. Patients in the control group were given regular health education and follow-up, and the observation group implemented a family pharmacist responsibility system. The scores of the Warfarin anticoagulation knowledge questionnaire, the medication compliance questionnaire, the standard rate of the international normalized ratio (INR) and the occurrence of complications of patients were compared between the two groups after one year of intervention. Results The scores of Warfarin anticoagulant knowledge questionnaire, medication compliance questionnaire and the standard rate of INR at one year after discharge in observation group were higher than those in the control group (all P < 0.05). The incidence of bleeding and thrombosis complications in the observation group were lower than those in the control group (P < 0.05). Conclusion Family pharmacist responsibility system could significantly improve the awareness, treatment compliance of Warfarin anticoagulant and the standard rate of INR in AF patients, and can reduce the incidence of bleeding and thrombotic complications.
|
|
|
|
|
[1] 张清.高血压伴阵发性房颤患者心脏超声临床特点[J].转化医学电子杂志,2015,2(7):21-22.
[2] 吕游,杨杰孚.CYP2C9基因多态性在房颤患者华法林抗凝治疗中的意义[J].中国医药导报,2017,14(20):4-7.
[3] 陶爱伟,倪水妹,费杏珍,等.医院-社区-家庭无缝隙管理模式在房颤患者服用华法林期间的应用研究[J].护士进修杂志,2018,33(7):661-663.
[4] 吴玉萍,李斌,林小洁,等.医护联合责任组对经导管射频消融治疗心房颤动患者健康教育的影响[J].中国医药导报,2018,15(28):161-163,181.
[5] 刘及贤,余早红,骆燕萍,等.家庭医生服务制模式下社区抑郁症防治工作的探讨[J].中国现代医药杂志,2018, 20(6):42-44.
[6] 葛运芬,王希,李敏,等.家庭医生签约式干预对社区高血压患者血压控制效果的影响[J].山东医药,2016,56(33):73-75.
[7] 倪金燕,白朝晖,缪栋蕾,等.家庭医生制服务对高血压患者家庭管理的效果评价研究[J].中国全科医学,2012, 15(31):3595-3597.
[8] 朱秀国,徐先锋.家庭医生制团队参与糖尿病前期患者管理的研究[J].中国社区医师,2015,(10):161-162,164.
[9] 姚义景,王彩燕.家庭医生签约对社区高脂血症患者的干预效果评价[J].心理医生,2017,23(14):254.
[10] 吴晓玲,于国超.家庭药师服务标准与路径专家共识[J].药品评价,2018,15(16):4-16.
[11] 吴晓玲,谢奕丹,邱宇翔,等.家庭药师制度的构建与实践探索[J].今日药学,2018,28(5):340-343,348.
[12] 徐炳林,徐颂敬,符艳芬.某基层医院开展家庭药师用药服务的实践与体会[J].感染药学,2019,16(5):781-783.
[13] 中华医学会心电生理和起搏分会,中国医师协会心律学专业委员会心房颤动防治专家工作委员会.心房颤动:目前的认识和治疗建议-2015[J].中华心律失常学杂志,2015,19(5):321-384
[14] 方曙静,林征,孙国珍,等.射频消融心房颤动患者华法林抗凝依从性及其影响因素的调查分析[J].中华护理杂志,2011,46(2):161-163.
[15] 中华医学会心血管病学分会,中国老年学学会心脑血管病专业委员会.华法林抗凝治疗的中国专家共识[J].中华内科杂志,2013,52(1):76-82.
[16] 刘岩华,刘畅,汤日波,等.护理干预提高心房颤动患者导管消融术后的抗凝依从性研究[J].心肺血管病杂志,2015,34(9):716-718.
[17] 沈鹏悦,刘晓珊,李瑞锋,等.我国家庭医生签约服务发展现状分析[J].中国医药导报,2017,14(26):169-172.
[18] 袁立,周昌明,江萍,等.上海市长宁区居民家庭医生制服务的需求情况调查[J].中国全科医学,2014,17(32):3860-3864.
[19] 杨淑颖.开展社区药学服务的体会和工作方法探讨[J].世界最新医学信息文摘,2018,18(59):192.
[20] Yang JD,Meng L,Liu Y,et al. Drug-related problems among community-dwelling older adults in mainland China [J]. Int J Clln Pharm,2018,40(2):1-8.
[21] 陈蓉,周磊,秦琼,等.SIMPLE药学服务模式在支气管哮喘、COPD患者慢病管理中的实践及效果研究[J].中国药房,2018,29(10):1400-1403.
[22] 何粤红,杨春霞,于海燕,等.浅析慢病管理的药学服务新模式[J].世界最新医学信息文摘,2017,17(89):231.
[23] Faruquee CF,Khera AS,Guirguis LM. Family physicians' perceptions of pharmacists prescribing in Alberta [J]. J Interprof Care,2020,34(1):87-96.
[24] 江莲,刘钰.家庭医生团队中药学服务型药师的培养[J].重庆医学,2018,47(12):1694-1695.
[25] 王可,侯凯旋,闫素英.国内外药物治疗管理开展现状[J].中国药房,2018,29(5):580-586. |
|
|
|